American Century Companies’s Calithera Biosciences, Inc CALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-27,645
Closed -$2.77M 1380
2018
Q2
$2.77M Sell
27,645
-12,191
-31% -$1.38M ﹤0.01% 960
2018
Q1
$5.02M Buy
39,836
+9,680
+32% +$1.51M 0.01% 833
2017
Q4
$5.04M Buy
30,156
+8,918
+42% +$2.28M 0.01% 847
2017
Q3
$6.69M Buy
21,238
+15,541
+273% +$4.9M 0.01% 770
2017
Q2
$1.69M Buy
+5,697
New +$1.52M ﹤0.01% 1066

Other funds holding CALA

American Century Companies's CALA Position: Q3 2018 in Review

American Century Companies sold out of Calithera Biosciences, Inc (CALA) in Q3 2018, closing a stake of 27,645 shares — an estimated $2.77M sold.

American Century Companies first reported a position in CALA in Q2 2017 and held it in 5 quarters. The position peaked at $6.69M in Q3 2017. 81 funds tracked by Wall St. Rank hold CALA as of Q3 2018.

  • American Century Companies reported no remaining Calithera Biosciences, Inc position as of Q3 2018 after selling out during the quarter.
  • American Century Companies sold 27,645 Calithera Biosciences, Inc shares in Q3 2018, an estimated $2.77M.
  • American Century Companies first reported a position in Calithera Biosciences, Inc in Q2 2017 and held it in 5 quarters.
  • American Century Companies's Calithera Biosciences, Inc position peaked at $6.69M in Q3 2017.
  • 81 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2018.

Based on American Century Companies's 13F filing for Q3 2018, filed 2 Nov 2018.